Study guide

11.1 Kidney Transplant I: Candidacy, Living Donors & the Early Post-Transplant Period

Board Certified Specialist in Renal Nutrition CSR

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Kidney Disease Foundations

1.1 CDR CSR Exam Structure, Eligibility, Logistics & the 2023 Content Outline 1.2 Renal Anatomy, Physiology & Glomerular Hemodynamics 1.3 CKD Etiology, KDIGO Staging & Progression Risk

2 Chapter 2: Domain 1 — Anthropometric & Body Composition Assessment

2.1 Dry Weight Determination, Fluid Assessment & Interdialytic Weight Gain 2.2 Anthropometric Measurement Standards (Knee Height, Skinfolds, Frame Size) 2.3 Body Composition Analysis: BIA, BIS, DXA & Handgrip Dynamometry

3 Chapter 3: Domain 1 — Nutrition-Focused Physical Findings & PEW Assessment Tools

3.1 Protein-Energy Wasting (PEW) Diagnostic Criteria & Pathophysiology 3.2 Subjective Global Assessment (7-Point SGA) in Dialysis 3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols 3.4 Nutrition-Focused Physical Exam (NFPE) for Muscle & Fat Loss

4 Chapter 4: Domain 1 — Diet, Medical, Medication & Psychosocial History

4.1 Dietary Intake Assessment & Food Frequency Methods in CKD 4.2 Medical & Medication History: Drug–Nutrient Interactions and Supplements 4.3 Psychosocial, Social & Functional History in Renal Nutrition Assessment

5 Chapter 5: Domain 1 — Medical Tests & Procedures by Treatment Modality

5.1 Hemodialysis Clinical Assessment & Vascular Access Considerations 5.2 Peritoneal Dialysis & Peritoneal Glucose Absorption Assessment 5.3 AKI, CRRT & Pediatric Renal Disease Assessment

6 Chapter 6: Domain 1 — Nutrition Diagnosis: Terminology, Etiology & Reasoning

6.1 Standardized Nutrition Diagnostic Terminology (NCP) in Nephrology 6.2 Etiology & Root-Cause Analysis for Renal Nutrition Problems 6.3 Diagnostic Reasoning for Fluid, Mineral & Protein Imbalances

7 Chapter 7: Domain 1 — Nutrition Diagnosis in Complex Patients

7.1 Formulating Valid PES Statements in Complex Dialysis Patients 7.2 Differentiating PEW, Sarcopenia & Cachexia in CKD 7.3 Diagnostic Prioritization across Cardiorenal & Diabetic Nephropathy

8 Chapter 8: Domain 2 — Food & Nutrient Delivery: Protein & Energy

8.1 KDOQI 2020 Protein Targets: Non-Dialysis CKD (LPD vs. VLPD) 8.2 Protein Prescriptions for Hemodialysis and Peritoneal Dialysis 8.3 Energy Requirements, Carbohydrates & Plant-Dominant Diets (PLADO)

9 Chapter 9: Domain 2 — Electrolytes, Fluid, Acid–Base & Micronutrients

9.1 Potassium Management: Dietary Restriction, Leaching & K-Binders 9.2 Sodium & Fluid Prescriptions across Dialysis Modalities 9.3 Acid-Base Homeostasis & Bicarbonate Replacement Therapy 9.4 Micronutrient, Trace Mineral & Vitamin Supplementation in ESRD

10 Chapter 10: Domain 2 — Medications & Specialized Nutrition Support

10.1 CKD-MBD Pharmacology: Phosphorus Binders, Vitamin D & Calcimimetics 10.2 Anemia Management: Iron Homeostasis, IV Iron Protocols & ESAs 10.3 Enteral, IDPN & Intraperitoneal Amino Acid Nutrition Support

11 Chapter 11: Domain 2 — Treatments Across the Continuum: Transplant & Comorbidities

11.1 Kidney Transplant I: Candidacy, Living Donors & the Early Post-Transplant Period 11.2 Kidney Transplant II: Long-Term Care, Immunosuppressant Side Effects & Graft Protection 11.3 Diabetes Management Across CKD Stages: Glycemic Targets, Medications & MNT 11.4 GI & Cardiovascular Comorbidities: Gastroparesis, Constipation, Liver Disease, Lipids & Blood Pressure

12 Chapter 12: Domain 2 — Monitoring & Evaluation: Labs, Fluid & Nutrition Trends

12.1 Renal Laboratory Surveillance: Frequency, Target Ranges & Trending 12.2 Monitoring Fluid Balance, Blood Pressure & Cardiovascular Risk 12.3 Longitudinal Assessment of Nutritional Status & Weight Trajectories

13 Chapter 13: Domain 2 — Monitoring Dialysis Adequacy & Kinetics

13.1 Hemodialysis Adequacy: Urea Kinetic Modeling, spKt/V & URR 13.2 Peritoneal Dialysis Adequacy & Peritoneal Equilibration Test (PET) 13.3 Normalized Protein Catabolic Rate (nPCR / nPNA) Interpretation 13.4 Troubleshooting Inadequate Dialysis vs. Dietary Non-Adherence

14 Chapter 14: Domain 2 — Care Coordination, Communication & Education

14.1 Interdisciplinary Team Care, Patient Education & Counseling Ethics 14.2 Individualized & Group Education: Medicare MNT and KDE Benefits, Caregivers & Curricula 14.3 Interfacility Coordination of Care: Hospital Handoffs, Transfers, Transplant Centers & Modality Changes 14.4 Psychosocial Support & Resources: Food Assistance, Financial Programs, Rehabilitation & Peer Support

15 Chapter 15: Domain 3 — Regulations & Quality Management

15.1 CMS Conditions for Coverage: IDT, Dietitian Qualifications, Assessment & Plan-of-Care Timelines 15.2 QAPI Programs, PDSA Cycles & the ESRD Quality Incentive Program 15.3 Medicare ESRD Payment, ESRD Networks, EQRS & the Survey Measures Assessment Tool

16 Chapter 16: Domain 3 — Evidence-Based Practice: Guidelines, Research & Protocols

16.1 The KDOQI 2020 Nutrition in CKD Guideline (NKF–Academy EAL): Grades & Key Statements 16.2 KDIGO & Companion Guidelines: CKD 2024, CKD-MBD, Anemia 2026, Diabetes, BP, Lipids & AKI 16.3 Appraising Current Research: Study Designs, Bias, Statistics & Landmark Renal Trials 16.4 Clinical Protocols & Algorithms: Dietitian-Managed MBD, Anemia, Potassium & Nutrition-Support Pathways

11.1 Kidney Transplant I: Candidacy, Living Donors & the Early Post-Transplant Period

Key Takeaways Explain This Topic AI

Dialysis facilities must evaluate every patient for transplant referral and communicate with the transplant center at least annually and whenever candidacy changes (42 CFR 494.80(a)(10), 494.90(c)).

Transplant programs must make nutrition assessment and diet counseling by a CDR-registered dietitian available to all transplant patients and living donors (42 CFR 482.94(e)).

Commonly used early post-transplant targets (about the first 6–8 weeks) are 30–35 kcal/kg and 1.2–2.0 g protein/kg per day, reflecting surgical stress and high-dose corticosteroids.

Post-transplant hypophosphatemia is common because FGF-23 and PTH stay high; KDOQI 2020 statement 6.3.3 supports high-phosphorus foods or supplements to replete it.

Immunosuppressed recipients need lifelong food-safety practices: no raw or undercooked meat, eggs or seafood, no unpasteurized dairy or juice, and no raw sprouts.

Last updated: September 2026

Why transplant belongs on the CSR exam

Kidney transplantation is the preferred kidney replacement therapy for eligible patients, and the CSR outline lists transplant as a treatment setting in Domain 2. The CDR reference list includes the KDIGO transplant-recipient guideline and State Operations Manual Appendix X , the survey guidance for transplant programs. A renal dietitian may meet a transplant patient at three points: in the dialysis unit before listing, on the transplant team, or in clinic years later when the graft is failing.

Regulatory duties before transplant

The dialysis facility's duties come from the ESRD Conditions for Coverage:

The comprehensive assessment must evaluate suitability for transplant referral , using criteria developed by the prospective transplant center. If the patient is not referred, the reason must be documented (42 CFR 494.80(a)(10)).

The plan of care must document the transplant plan, the patient's decision to decline referral, or the reason for non-referral (§494.90(a)(7)(ii)).

The interdisciplinary team must track referral results , monitor wait-listed patients, and communicate with the transplant center at least annually and whenever candidate status changes (§494.90(c)).

Waitlisting is also a quality measure. The PY 2028 ESRD Quality Incentive Program includes Percentage of Prevalent Patients Waitlisted (PPPW) as a clinical measure.

Transplant programs have their own Medicare conditions of participation. Under 42 CFR 482.94(e) , a transplant program must make nutritional assessments and diet counseling, furnished by a qualified dietitian, available to all transplant patients and living donors . The regulation defines a qualified dietitian as someone who meets state practice requirements and is registered with CDR.

Nutrition issues in transplant candidacy

Each center sets its own listing criteria. Nutrition findings that commonly delay or block listing include:

Obesity. Many programs set an upper BMI limit. KDIGO's candidate guidance favors assessing body composition and risk rather than excluding on BMI alone. Dietitians help with supervised weight loss; some candidates use GLP-1 receptor agonists or bariatric surgery. After bariatric surgery, watch for enteric hyperoxaluria and micronutrient deficiencies.

Protein-energy wasting and frailty. Low muscle mass and frailty predict poor surgical outcomes. Build strength and nutrient reserves before surgery with MNT, supplements and exercise referral.

Uncontrolled diabetes, adherence concerns and substance use are evaluated by the team, often with dietitian input on diet history and self-management.

Candidate education should prepare the patient for the diet change after transplant. Many restrictions (potassium, phosphorus, fluid) usually ease, while sodium control, weight management, glucose control and food safety become central.

Living donors

Living donors are evaluated for kidney health, blood pressure, glucose and weight. The dietitian may assess diet quality, counsel on reaching a healthy weight before donation, and after donation reinforce a heart-healthy pattern with moderate sodium, weight maintenance and avoidance of NSAIDs. A donor with one kidney has less reserve, so long-term blood pressure and weight control matter.

The early post-transplant period (about the first 6–8 weeks)

Surgery, high-dose corticosteroids and fluid and electrolyte shifts make the first weeks catabolic. Commonly cited targets (Academy and NKF transplant nutrition references) are:

  • Nutrient Early period Notes
  • Energy 30–35 kcal/kg Use the lower end for obesity and the upper end for underweight or catabolic patients
  • Protein 1.2–2.0 g/kg Protein catabolism is highest in the first weeks and during steroid pulses for rejection

Carbohydrate Emphasize complex carbohydrate; limit concentrated sweets Steroids and tacrolimus cause hyperglycemia

  • Sodium Individualize; commonly about 2–3 g/day Tighter if hypertensive or edematous
  • Potassium Individualize to the serum level Calcineurin inhibitors and trimethoprim can raise potassium

Phosphorus and magnesium Often need high-phosphorus foods or supplements , and magnesium supplements Persistent FGF-23 and PTH cause phosphate wasting; calcineurin inhibitors cause magnesium wasting

Fluid Follow the transplant center's order A functioning graft often needs generous fluid; delayed graft function needs dialysis-style limits

KDOQI 2020 statement 6.3.3 says that for adults after transplant with hypophosphatemia, it is reasonable to prescribe a high-phosphorus intake (diet or supplements) to replete serum phosphate. The same guideline extends its energy statement (25–35 kcal/kg for stable patients), sodium limit (<2.3 g/day) and potassium individualization to transplant recipients.

Delayed graft function. If the new kidney does not work right away, the patient may need dialysis for days or weeks. Nutrition then follows dialysis-level protein needs and individualized fluid, potassium and phosphorus limits until urine output recovers.

Hyperglycemia after transplant

Corticosteroids and tacrolimus impair insulin secretion and action. Transient hyperglycemia is common right after surgery. The international consensus on post-transplant diabetes mellitus (PTDM) advises making the formal diagnosis only once the patient is stable on maintenance immunosuppression. Early on, the dietitian teaches consistent carbohydrate intake and works with the team on insulin plans.

Food safety

Immunosuppression raises the risk of foodborne illness (Listeria, Salmonella, Toxoplasma, norovirus). The federal food-safety guidance for transplant recipients advises:

  • no raw or undercooked meat, poultry, eggs, fish or shellfish (including sushi and raw oysters);
  • no unpasteurized milk, cheese or juice, and no soft cheeses made from unpasteurized milk;
  • heating deli meats and hot dogs until steaming hot;
  • no raw sprouts;

careful washing of produce, prompt refrigeration and separate cutting boards for raw meat.

Teach these before discharge and repeat them at follow-up. The risk lasts as long as immunosuppression continues.

Drug–food interactions to teach at discharge

Grapefruit, pomelo and Seville orange raise tacrolimus and cyclosporine levels. St. John's wort lowers them.

Tacrolimus should be taken the same way relative to meals every day, because food changes its absorption.

Mycophenolate commonly causes nausea and diarrhea, which can drive weight loss and electrolyte losses.

Coverage notes that affect nutrition care

Medicare Part B covers medical nutrition therapy for 36 months after a kidney transplant (42 CFR 410.130). For people entitled to Medicare only because of kidney failure, Medicare ends 36 months after a successful transplant. Since 2023, the Part B immunosuppressive drug benefit (Part B-ID) lets eligible people keep immunosuppressant coverage after that date.